Research Reports Initiated on Biotech Stocks Helius Medical Technologies, Aurinia Pharma, Telesta Therapeutics, and Aeterna Zentaris

LONDON, UK / ACCESSWIRE / September 30, 2016 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Healthcare Sector. Companies recently under review include Helius Medical Technologies, Aurinia Pharma, Telesta Therapeutics, and Aeterna Zentaris. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.

At the close of the Canadian markets on Thursday, September 29, 2016, the Toronto Exchange Composite index ended the trading session at 14,754.55, 0.16% higher from its previous closing price.

The Healthcare Index was in the red, closing the day at 81.97, down 0.95%.

Active Wall St. has initiated research reports on the following equities: Helius Medical Technologies Inc. (TSX: HSM), Aurinia Pharmaceuticals Inc. (TSX: AUP), Telesta Therapeutics Inc. (TSX: TST), and Aeterna Zentaris Inc. (TSX: AEZ). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.

Helius Medical Technologies Inc.

On Thursday, shares in Newtown, Pennsylvania headquartered Helius Medical Technologies Inc. ended the session 3.85% higher at $1.35 with a total volume of 67,092 shares traded. Shares of Helius Medical Technologies, which operates as a medical technology company focused on neurological wellness, have gained 17.39% in the last one month. The stock is trading above its 50-day and 200-day moving averages. The company’s 200-day moving average of $1.28 is greater than its 50-day moving average of $1.23. See our research report on HSM.TO at: http://www.activewallst.com/registration-3/?symbol=HSM.

Aurinia Pharmaceuticals Inc.

Victoria, Canada headquartered clinical stage pharmaceutical company, Aurinia Pharmaceuticals Inc.’s stock gained 8.75%, to close the day at $3.48. The stock recorded a trading volume of 120,397 shares, which was above its three months average volume of 43,274 shares. Shares of Aurinia Pharmaceuticals, which engages in the development of a therapeutic drug to treat autoimmune diseases in Canada, have surged 35.94% in the previous one month. The company’s shares are trading above their 50-day moving average. Moreover, the stock’s 200-day moving average of $3.53 is greater than its 50-day moving average of $3.00. The complimentary research report on AUP.TO at: http://www.activewallst.com/registration-3/?symbol=AUP.

Telesta Therapeutics Inc.

Pointe-Claire, Canada headquartered biopharmaceutical company, Telesta Therapeutics Inc.’s stock finished Thursday’s session flat at $0.14 with a total volume of 326,602 shares traded. Shares of Telesta Therapeutics, which engages in the research, development, manufacture, and commercialization of human health products and technologies globally, have rallied 80.00% in the previous three months. The Company’s shares are trading above its 50-day and 200-day moving averages. Telesta Therapeutics’ 50-day moving average of $0.12 is above its 200-day moving average of $0.09. Register for free and access the latest research report on TST.TO at: http://www.activewallst.com/registration-3/?symbol=TST.

Aeterna Zentaris Inc.

On Thursday, shares in Summerville, South Carolina headquartered specialty biopharmaceutical company, Aeterna Zentaris Inc., recorded a trading volume of 7,919 shares. The stock ended the day 0.22% lower at $4.50. Shares of Aeterna Zentaris, which engages in developing and commercializing novel treatments in oncology, endocrinology, and women’s health, have advanced 6.38% in the past three months. The Company is trading below its 50-day and 200-day moving averages. The stock’s 50-day moving average of $4.63 is above its 200-day moving average of $4.60. Get free access to your research report on AEZ.TO at: http://www.activewallst.com/registration-3/?symbol=AEZ.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 446298